Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Non-cash Items (2016 - 2018)

Historic Non-cash Items for Alaunos Therapeutics (TCRT) over the last 8 years, with Q3 2018 value amounting to $2.9 million.

  • Alaunos Therapeutics' Non-cash Items rose 844.2% to $2.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $2.9 million, marking a year-over-year increase of 844.2%. This contributed to the annual value of $2.9 million for FY2017, which is 949.41% up from last year.
  • Latest data reveals that Alaunos Therapeutics reported Non-cash Items of $2.9 million as of Q3 2018, which was up 844.2% from $415000.0 recorded in Q2 2018.
  • Alaunos Therapeutics' Non-cash Items' 5-year high stood at $39.6 million during Q1 2015, with a 5-year trough of $415000.0 in Q2 2018.
  • For the 5-year period, Alaunos Therapeutics' Non-cash Items averaged around $4.8 million, with its median value being $2.8 million (2014).
  • Per our database at Business Quant, Alaunos Therapeutics' Non-cash Items skyrocketed by 129117.45% in 2015 and then crashed by 9463.57% in 2016.
  • Alaunos Therapeutics' Non-cash Items (Quarter) stood at $3.8 million in 2014, then plummeted by 43.91% to $2.1 million in 2015, then rose by 25.98% to $2.7 million in 2016, then rose by 9.49% to $2.9 million in 2017, then dropped by 0.03% to $2.9 million in 2018.
  • Its Non-cash Items stands at $2.9 million for Q3 2018, versus $415000.0 for Q2 2018 and $1.0 million for Q1 2018.